gmp-verlag.de
 

Never ever a 483?

We can not promise that you will never get a 483
but we know that the GMP MANUAL includes all 
procedures and processes you need to be
GMP compliant.
 
Shopping cart
Your shopping cart is empty

Show shopping cart...
 
 
PDA Parenterals Conference

From 26-28 October, 2010 the PDA Parenterals Conference will be held in Berlin.

This outstanding event will cover the very important topics:

  • Future of Parenterals
  • Packaging and Impact on Quality
  • Manufacturing Flexibility and Control
  • Innovative Plants
  • Monitoring Technologies
  • Medical and Application Devices
  • Regulatory Trends

Don´t miss this interesting conference in Berlin, Germany.

Brochure of PDA Parenterals Conference 2010, October 26-28

 

News about GMP/cGMP

NEW FDA Risk Guidance

FDA Issues Draft Guidance on Risk Evaluation and Mitigation Strategies (REMS)

The U.S. Food and Drug Administration today announced the availability of the first draft guidance for industry on Risk Evaluation and Mitigation Strategies or REMS, which are required for certain drugs or biologics in the submission process.

 

This guideline is not relevant for the GMP related areas but it covers a lot of quality and security topics within the submission process. If you are in charge of this areas this draft guidance may be interesting for you.

Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research, said to this guidance: “With this new guidance, manufacturers will have a useful blueprint for how to develop these important safety strategies.”

Link to the draft guidance at the FDA website

Source: FDA Press Release September 30, 2009

Comments
No comment have jet been written about this news